David Bejker

Director/Board Member at ABLIVA AB

51 year

Health Technology

Finance

Consumer Services

Profile

David Bejker is currently Chief Executive Officer at Affibody Medical AB since 2018.
He is an Independent Director at Abliva AB since 2017.
He is also a Director at Amylonix AB and Disruptive Pharma Holding AB. Formerly, Mr. Bejker was Chief Executive Officer & Director at Affibody AB from 2003 to 2005.
Other former roles include Deputy Director at Nexstim Oyj, Independent Director at LIDDS AB, and Principal at HealthCap AB. Education includes graduate studies at Stockholm School of Economics.

David Bejker active positions

Companies	Position	Start
ABLIVA AB	Director/Board Member	27/04/2017
Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services	Chief Executive Officer	01/12/2018
Amylonix AB Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area	Director/Board Member	-
Disruptive Pharma Holding AB	Director/Board Member	-

All active positions of David Bejker

Former positions of David Bejker

Companies	Position	End
Affibody AB Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment	Chief Executive Officer	01/07/2005
LIDDS AB	Director/Board Member	-
NEXSTIM PLC	Corporate Officer/Principal	-
HealthCap AB HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements.	Corporate Officer/Principal	-

See the detail of David Bejker's experience

Training of David Bejker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Bejker's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Affibody AB Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment	Health Technology
Abliva AB Abliva AB Pharmaceuticals: MajorHealth Technology Develops medicines for the treatment of mitochondrial diseases	Health Technology
HealthCap AB HealthCap AB Investment ManagersFinance HealthCap invests in companies located across the globe. The firm targets companies operating in the field of the life sciences. It provides financing for early stage capital requirements.	Finance
Affibody Medical AB Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services	Health Technology
Stockholm School of Economics Stockholm School of Economics Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Nexstim Oyj Nexstim Oyj Medical SpecialtiesHealth Technology Develops non-invasive brain stimulation technology	Health Technology
LIDDS AB LIDDS AB Pharmaceuticals: MajorHealth Technology Focuses on the development of treatment alternatives and hormonal therapy for prostate cancer	Health Technology
Amylonix AB Amylonix AB Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals focused on neurodegenerative area	Health Technology
Disruptive Pharma Holding AB